PT2263680E - Composições farmacêuticas comprimidas compreendendo peg e electrólitos - Google Patents

Composições farmacêuticas comprimidas compreendendo peg e electrólitos Download PDF

Info

Publication number
PT2263680E
PT2263680E PT101770071T PT10177007T PT2263680E PT 2263680 E PT2263680 E PT 2263680E PT 101770071 T PT101770071 T PT 101770071T PT 10177007 T PT10177007 T PT 10177007T PT 2263680 E PT2263680 E PT 2263680E
Authority
PT
Portugal
Prior art keywords
electrolytes
compressed pharmaceutical
peg
pharmaceutical compositions
polyethylene glycol
Prior art date
Application number
PT101770071T
Other languages
English (en)
Inventor
Norman Barras
Ian Cox
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of PT2263680E publication Critical patent/PT2263680E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT101770071T 2004-04-23 2005-04-25 Composições farmacêuticas comprimidas compreendendo peg e electrólitos PT2263680E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0409104.7A GB0409104D0 (en) 2004-04-23 2004-04-23 Compressed pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PT2263680E true PT2263680E (pt) 2014-11-19

Family

ID=32344298

Family Applications (2)

Application Number Title Priority Date Filing Date
PT101770071T PT2263680E (pt) 2004-04-23 2005-04-25 Composições farmacêuticas comprimidas compreendendo peg e electrólitos
PT05735983T PT1742645E (pt) 2004-04-23 2005-04-25 Composições farmacêuticas comprimidas compreendendo peg e electrólitos

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT05735983T PT1742645E (pt) 2004-04-23 2005-04-25 Composições farmacêuticas comprimidas compreendendo peg e electrólitos

Country Status (22)

Country Link
US (1) US20070298100A1 (pt)
EP (2) EP1742645B1 (pt)
JP (1) JP2007533719A (pt)
KR (1) KR20070001280A (pt)
CN (1) CN1950097A (pt)
AT (1) ATE496626T1 (pt)
AU (1) AU2005235345B8 (pt)
BR (1) BRPI0510175A (pt)
CA (1) CA2561649C (pt)
DE (1) DE602005026117D1 (pt)
DK (2) DK1742645T3 (pt)
ES (2) ES2361816T3 (pt)
GB (1) GB0409104D0 (pt)
IL (1) IL178722A0 (pt)
MX (1) MXPA06011906A (pt)
NO (1) NO20064780L (pt)
PL (2) PL2263680T3 (pt)
PT (2) PT2263680E (pt)
RU (1) RU2006137347A (pt)
SI (2) SI1742645T1 (pt)
WO (1) WO2005102364A1 (pt)
ZA (1) ZA200608496B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1877039A4 (en) * 2005-05-06 2010-08-18 Salix Pharmaceuticals Inc Polyethylene glycol GUT CLEANING COMPOSITION
ES2278537B1 (es) * 2006-01-30 2008-09-16 Laboratorios Casen-Fleet, S.L. Procedimiento de fabricacion de una solucion a base de polietilenglicol con electrolitos, producto obtenido y uso.
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
US8784872B2 (en) * 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
CN102057120B (zh) 2008-06-06 2014-07-30 诺托·弗朗克股份有限公司 用于窗、门或者类似物体的开启装置
WO2009158667A2 (en) * 2008-06-27 2009-12-30 Comgenrx, Inc. Povidone compositions for wound healing
WO2010123901A1 (en) 2009-04-21 2010-10-28 Bachwich Dale R Colon lavage system
EP2657243A1 (en) * 2009-06-03 2013-10-30 Aptalis Pharma Canada, Inc. L-Sugar Colon Cleansing Agent and Uses Thereof
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
EP2509695A1 (en) * 2009-12-07 2012-10-17 Aptalis Pharma Canada, Inc. Methods for purifying monosaccharide mixtures containing ionic impurities
CN101766648B (zh) * 2010-03-02 2012-01-11 舒泰神(北京)生物制药股份有限公司 聚乙二醇电解质颗粒制剂及其制造方法
DE202010012256U1 (de) * 2010-09-07 2010-11-11 Krewel Meuselbach Gmbh Abführmittel
AU2011100528B4 (en) * 2011-05-10 2011-08-25 Norgine Bv Formulations
MY164204A (en) * 2010-11-04 2017-11-30 Norgine Bv Formulations comprising polyethylene glycol
FI9608U1 (fi) * 2010-11-04 2012-03-29 Norgine Bv Formulaatiot
DE202010016235U1 (de) 2010-12-06 2011-05-19 Norgine B.V. Formulierungen
JP5870119B2 (ja) 2011-01-28 2016-02-24 ブレインツリー ラボラトリーズ、インク. 腸洗浄のための、方法、組成物、およびパッケージ
CN107260661A (zh) * 2011-01-31 2017-10-20 诺金股份有限公司 对组合物的改进和与组合物有关的改进
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
CN102133225B (zh) * 2011-03-18 2012-11-21 海南锦瑞制药股份有限公司 一种复方聚乙二醇电解质散剂及其制备方法
US20150056140A1 (en) * 2011-10-27 2015-02-26 Thomas Julius Borody Electrolyte purgatives
CN102600201B (zh) * 2012-02-07 2014-07-16 舒泰神(北京)生物制药股份有限公司 用于通便和清肠的药物组合物及其制备方法
CA3116204C (en) 2012-09-11 2023-09-12 Norgine Bv Colon cleansing composition comprising ascorbate and peg
RS59667B1 (sr) 2013-03-15 2020-01-31 Braintree Laboratories Inc Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe
CA2970651C (en) 2014-12-12 2020-09-29 Ojai Energetics Pbc Microencapsulated cannabinoid compositions
US10350165B2 (en) 2014-12-12 2019-07-16 Ojai Energetics Pbc Methods and systems for forming stable droplets
FR3056109B1 (fr) 2016-09-21 2019-10-11 Pierre Fabre Medicament Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation
CN107028876B (zh) * 2016-10-09 2020-09-29 舒泰神(北京)生物制药股份有限公司 聚乙二醇电解质口服液及其制备方法
WO2019016356A1 (en) 2017-07-20 2019-01-24 Solvay Sa FUNCTIONALIZED PARTICULATE BICARBONATE AS EXPANSION AGENT, FOAMABLE POLYMERIC COMPOSITION CONTAINING THE SAME, AND USE THEREOF IN THE PRODUCTION OF A FOAMED THERMOPLASTIC POLYMER
KR20190093491A (ko) 2018-02-01 2019-08-09 주식회사태준제약 장세척 조성물
WO2019151829A1 (ko) * 2018-02-01 2019-08-08 주식회사태준제약 장세척 조성물
CN110433174A (zh) * 2019-07-17 2019-11-12 华南理工大学 一种高依从性的复方聚乙二醇电解质散剂及其制备方法与应用
CN111617102B (zh) * 2020-05-25 2022-05-31 南京金凯木纳米材料有限公司 一种含聚乙二醇的电解质散剂及其制备方法
JP2023549291A (ja) * 2020-10-26 2023-11-22 ブレーンツリー・ラボラトリーズ・インコーポレイテッド 結腸洗浄のための硫酸塩製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121663A (en) * 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
US5229132A (en) * 1985-02-22 1993-07-20 Grimberg Georges Serge Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time
WO1987000754A1 (en) * 1985-08-01 1987-02-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation
US5273758A (en) * 1991-03-18 1993-12-28 Sandoz Ltd. Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
US6121663A (en) * 1997-05-22 2000-09-19 Advanced Micro Devices, Inc. Local interconnects for improved alignment tolerance and size reduction
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
US6444198B1 (en) * 1999-02-22 2002-09-03 Smithkline Beecham Corporation Effervescent laxatives
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
AU2004290580A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic PEG solution concentrate
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent

Also Published As

Publication number Publication date
BRPI0510175A (pt) 2007-10-02
DK1742645T3 (da) 2011-05-09
CA2561649C (en) 2014-10-14
PL2263680T3 (pl) 2015-02-27
ES2519540T3 (es) 2014-11-07
SI2263680T1 (sl) 2015-01-30
AU2005235345B8 (en) 2011-05-12
NO20064780L (no) 2007-01-18
WO2005102364A1 (en) 2005-11-03
JP2007533719A (ja) 2007-11-22
GB0409104D0 (en) 2004-05-26
CA2561649A1 (en) 2005-11-03
PT1742645E (pt) 2011-04-29
IL178722A0 (en) 2007-02-11
ES2361816T3 (es) 2011-06-22
EP1742645A1 (en) 2007-01-17
RU2006137347A (ru) 2008-05-27
US20070298100A1 (en) 2007-12-27
EP1742645B1 (en) 2011-01-26
EP2263680B1 (en) 2014-08-27
EP2263680A1 (en) 2010-12-22
AU2005235345B2 (en) 2011-04-14
MXPA06011906A (es) 2007-01-25
ATE496626T1 (de) 2011-02-15
CN1950097A (zh) 2007-04-18
AU2005235345A1 (en) 2005-11-03
PL1742645T3 (pl) 2011-06-30
ZA200608496B (en) 2008-07-30
KR20070001280A (ko) 2007-01-03
DK2263680T3 (en) 2014-12-08
SI1742645T1 (sl) 2011-05-31
DE602005026117D1 (de) 2011-03-10

Similar Documents

Publication Publication Date Title
IL178722A0 (en) Compressed pharmaceutical compositions comprising peg and electrolytes
PL1758553T3 (pl) Kompozycje farmaceutyczne zawierające glikol polietylenowy o masie cząsteczkowej niższej niż 600 Daltonów
IL169469A (en) Folic acid derivatives containing disulfide bonds, their pharmaceutical compositions and their use
MXPA05012507A (es) Composiciones farmaceuticas de vareniclina.
WO2007039825A3 (en) Saccharide foamable compositions
WO2007044809A3 (en) Albumin-free botulinum toxin based pharmaceutical compositions containing a hyaluronidase and methods of use
WO2006052876A3 (en) Insecticidal compositions suitable for use in preparation of insecticidal granular fertilizer and insecticidal formulations
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
MX2009005205A (es) Conjugado de polietilenglicol-g-csf.
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
WO2005092362A3 (de) Pharmazeutisches kombinationspräparat enthaltend ein therapeutisches protein
WO2005041922A3 (en) Composition
DK1110550T4 (da) Præparat omfattende ascorbinsyre som hovedbestanddel og pektin
ATE442057T1 (de) Interessante nährstoff- und organoleptische eigenschaften zeigende lipidische zusammensetzung
GB0410616D0 (en) Antiperspirant or deodorant compositions
WO2006110185A3 (en) Antiinfective lipopeptides
ATE307579T1 (de) Pektin und ascorbinsäure enthaltende zusammensetzungen
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
WO2005072736A3 (en) Stable gabapentin compositions
HRP20090547T1 (en) Pharmaceutical compositions comprising zd6474
MX2008006476A (es) Composiciones de lipopeptidos.
IL191560A0 (en) 3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same
TW200511986A (en) Antifungal composition
WO2004011005A3 (en) Antimicrobial 2, 4-diamino-pteridine derivatives
EP1581156A4 (en) GILSONITE PHARMACEUTICAL DELIVERY COMPOSITIONS AND METHOD